Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

MRI in multiple sclerosis: a review of the current literature.
Secukinumab in the treatment of noninfectious uveitis: results of three randomized, controlled clinical trials.
Death receptor 6 negatively regulates oligodendrocyte survival, maturation and myelination.
Detection of MicroRNAs in Microglia by Real-time PCR in Normal CNS and During Neuroinflammation.
Study Suggests Targeting B Cells May Help with MS
A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy.
A Study to Evaluate the Long-term Safety, Tolerability and Effect of Daily Oral Laquinimod 0.6 mg on Disease Course in Subjects With Relapsing Multiple Sclerosis
Why did IL-12/IL-23 antibody therapy fail in multiple sclerosis?
Diagnosis of exclusion: a case report of probable glatiramer acetate-induced eosinophilic myocarditis.
Topical Application of Fingolimod Perturbs Cutaneous Inflammation.
Estimation of the effect of dalfampridine on health utility by mapping the MSWS-12 to the EQ-5D in multiple sclerosis patients.
Investigating Axonal Damage in Multiple Sclerosis by Diffusion Tensor Spectroscopy.
The age-range of risk of developing multiple sclerosis: evidence from a migrant population in Australia.
Patient page. Multiple sclerosis and vitamin D.
Microglia and brain macrophages in the molecular age: from origin to neuropsychiatric disease.
Efficacy and safety of secukinumab in the treatment of moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled phase II dose-ranging study.
Pilot trial of low-dose naltrexone and quality of life in multiple sclerosis.
Cerebrospinal fluid biomarkers of inflammation and degeneration as measures of fingolimod efficacy in multiple sclerosis.
Tysabri prescribing information
Separated at birth? The functional and molecular divergence of OLIG1 and OLIG2.
Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cells.
Long-term effects of dalfampridine in patients with multiple sclerosis.
Low-contrast visual tests reveal better alemtuzumab efficacy
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Evidence-based guideline: Assessment and management of psychiatric disorders in individuals with MS: Report of the Guideline Development Subcommittee of the American Academy of Neurology.

Pages